Angiogenesis

During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
C4321 Octyl-α-ketoglutarateSummary: prolyl hydroxylases (PHD) activator -
B5391 Echistatin, α1 isoformSummary: Potent irreversible αVβ3 integrin antagonist -
A8672 RLLFT-NH2Summary: Protease-activated receptor agonist -
B4862 CWHM-12Summary: inhibitor of αV integrins -
B5952 LFM-A13Summary: BTK-specific tyrosine kinase inhibitor -
B6106 Daprodustat(GSK1278863)Summary: HIF-prolyl hydroxylase inhibitor -
A8671 VKGILS-NH2Summary: control peptide for SLIGKV-NH2, PAR1 agonist -
B5851 FG2216Target: Pyruvate dehydrogenases (PDH)Summary: HIF-prolyl hydroxylase inhibitor -
B5941 ONO-4059Summary: Highly potent and selective oral Btk inhibitor -
B3708 RGD (Arg-Gly-Asp) Peptides1 CitationTarget: Integrin-ligand interactionsSummary: Inhibits integrin binding to RGD motifs
